PCRX Net Income Growth
111.48%TTM
Period ending:
PCRX TTM Net Income YoY %%
192778.43%-23133.56%
2011-06-302026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
PCRX net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 61 observations from Jun 30, 2011 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 111.4844% | |
| 104.9534% | |
| 107.0651% | |
| 123.6281% | |
| -300.4309% | |
| -247.1931% | |
| -337.3019% | |
| -1,399.3126% | |
| 1,492.141% | |
| 774.0316% | |
| 163.7186% | |
| -66.5581% | |
| -111.643% | |
| -127.1989% | |
| -62.1034% | |
| -66.116% | |
| -77.4626% | |
| -73.9809% | |
| -71.1525% | |
| -51.1382% | |
| 1,826.1676% | |
| 171,883.7209% | |
| 1,421.024% | |
| 5,747.0561% | |
| -232.6276% | |
| -101.1562% | |
| -2,238.8535% | |
| 151.8385% | |
| 168.3936% | |
| 122.2528% | |
| 98.8947% | |
| 91.8697% | |
| 83.0895% | |
| 38.0571% | |
| -12.2849% | |
| -40.3164% | |
| -485.7627% | |
| -1,556.2615% | |
| -2,144.6659% | |
| -459.1375% | |
| -376.0453% | |
| -232.7886% | |
| 113.5316% | |
| 132.2679% | |
| 109.4003% | |
| 98.1262% | |
| 78.5382% | |
| 53.9173% | |
| 37.5484% | |
| 17.7521% | |
| -22.2413% | |
| -33.3496% | |
| -53.9761% | |
| -39.7751% | |
| -20.6605% | |
| -45.9618% | |
| -34.3438% | |
| -44.1329% | |
| -59.597% | |
| -20.6837% | |
| -20.5776% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics
